Modern radiotherapy techniques versus three‐dimensional conformal radiotherapy for head and neck cancer
Referencias
Additional references
Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Handbook. 7th Edition. New York, NY: Springer, 2010.
Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston‐Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Research 1988;48(11):3282.
Brierley JD, Gospodarowicz MK, Wittekind C (editors). TNM Classification of Malignant Tumours. 8th Edition. Oxford, UK; Hoboken, USA: John Wiley & Sons, 2017.
National Cancer Institute. National Cancer Institute Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS 29 May 2009; Vol. NIH publication # 09‐7473.
Decker J, Goldstein JC. Risk factors in head and neck cancer. New England Journal of Medicine 1982;306(19):1151‐5.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.
Eisbruch A, Ten‐Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity‐modulated irradiation of head and neck cancer. International Journal of Radiation Oncology, Biology, Physics 1999;45:577‐87.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organisation for Research and Treatment of Cancer QLQ‐C30: a quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993;85:365‐76.
EORTC Quality of Life Study Group. The European Organisation for Research and Treatment of Cancer QLQ‐H&N35 [Journal of the National Cancer Institute]. http://groups.eortc.be/qol/sites/default/files/img/specimen_for_printing_hn35.pdf1994.
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber T, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New England Journal of Medicine 2003;349:2091‐8.
Ghosh–Laskar S, Yathiraj PH, Dutta D, Rangarajan V, Purandare N, Gupta T, et al. Prospective randomized controlled trial to compare 3‐dimensional conformal radiotherapy to intensity‐modulated radiotherapy in head and neck squamous cell carcinoma: long‐term results. Head & Neck 2016;38:E1481‐7.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute 2000;92:709‐20.
Gregoire V, Lefebvre JL, Licitra L, Felip E. Squamous cell carcinoma of the head and neck: EHNS‐ESMO‐ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Annals of Oncology 2010;21(Suppl 5):184‐6.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hardy RJ, Thompson SG. A likelihood approach to meta‐analysis with random effects. Statistics in Medicine 1996;15(6):619‐29.
Higgins KM, Shah MD, Ogaick MJ, Enepekides D. Treatment of early‐stage glottic cancer: meta‐analysis comparison of laser excision versus radiotherapy. Journal of Otolaryngology ‐ Head & Neck Surgery 2009;38(6):603‐12.
Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. International Journal of Radiation Oncology, Biology, Physics 2014;89(2):292‐302.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011;61(2):69.
Johnston M, Clifford S, Bromley R, Back M, Oliver L, Eade T. Volumetric‐modulated arc therapy in head and neck radiotherapy: a planning comparison using simultaneous integrated boost for nasopharynx and oropharynx carcinoma. Clinical Oncology 2011;23(8):503‐11.
Khan F. The Physics of Radiation Therapy. 4th Edition. Baltimore: Lippincott Williams & Wilkins, 2009.
Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, et al. Intensity‐modulated radiation therapy for head and neck cancer: systematic review and meta‐analysis. Radiotherapy and Oncology 2014;110(1):9‐15.
National Comprehensive Cancer Network. Head and Neck Cancers (Version 2.2014). http://www.nccn.org/professionals/physician_gls/pdf/head‐and‐neck.pdf (accessed 16 June 2014).
NCT01287390. Adaptive, image‐guided, intensity‐modulated radiotherapy for head and neck cancer in the reduced volumes of elective neck. https://clinicaltrials.gov/ct2/show/NCT01287390.
NCT01341535. A study comparing adaptive biological imaging ‐ voxel intensity ‐ based radiotherapy (adaptive dose escalation) versus standard radiotherapy for head and neck cancer. https://clinicaltrials.gov/ct2/show/NCT01341535.
NCT01874587. Adaptative radiotherapy to decrease xerostomia in oropharynx carcinoma (ARTIX). https://clinicaltrials.gov/ct2/show/NCT01874587.
NCT01893307. Randomized trial of intensity‐modulated proton beam therapy (IMPT) versus intensity‐modulated photon therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck. https://clinicaltrials.gov/ct2/show/NCT01893307.
NCT02923570. Study of proton versus photon beam radiotherapy in the treatment of head and neck cancer. https://clinicaltrials.gov/ct2/show/NCT02923570.
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid‐sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3multicentre randomised controlled trial. Lancet Oncology 2011;12:127‐36.
Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Medical Physics 2008;35(1):310‐7.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
RTOG/EORTC. RTOG/EORTC Late Radiation Morbidity Scoring. https://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx.
Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Research 1998;18(6B):4779.
Ware JE, Sherbourne CD. The MOS 36‐Item Short‐Form Health Survey (SF‐36): I. Conceptual Framework and Item Selection. Medical Care 1992;30:473‐83.
